Evidence map›Paper›PMID 39734389›Full record

ArticleACG case reports journal2025

Double Whammy: A Case Report of Immune Checkpoint Inhibitor Colitis and Concomitant

Misha Gautam, Vinay Jahagirdar, Himil Mahadevia, Kimberly Sanders, John P Campbell, Pamela B Sylvestre, Rajiv Chhabra, Wendell Clarkston, Sreenivasa S Jonnalagadda

Abstract readCase Reports
In one paragraph

Article in ACG case reports journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Misha GautamInternal Medicine, University of Missouri-Kansas City School of Medicine, Kansas City, MO.ORCID https://orcid.org/0000-0002-3826-2132
Vinay JahagirdarInternal Medicine, University of Missouri-Kansas City School of Medicine, Kansas City, MO.
Himil MahadeviaInternal Medicine, University of Missouri-Kansas City School of Medicine, Kansas City, MO.
Kimberly SandersGastroenterology and Hepatology, University of Missouri-Kansas City School of Medicine, Kansas City, MO.
John P CampbellGastroenterology, Saint Luke's Hospital of Kansas City, Kansas City, MO.
Pamela B SylvestrePathology, Emory University School of Medicine, Atlanta, GA.
Rajiv ChhabraGastroenterology and Hepatology, University of Missouri-Kansas City School of Medicine, Kansas City, MO.
Wendell ClarkstonGastroenterology and Hepatology, University of Missouri-Kansas City School of Medicine, Kansas City, MO.
Sreenivasa S JonnalagaddaGastroenterology and Hepatology, University of Missouri-Kansas City School of Medicine, Kansas City, MO.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Immune checkpoint inhibitors commonly cause gastrointestinal immune-related adverse effects. These patients also carry an increased risk of concomitant infections. This 66-year-old man with immune checkpoint inhibitor colitis was discovered to have concurrent

Indexed as

CMV colitisimmune checkpoint inhibitor colitisimmune checkpoint inhibitorsimmune-related adverse effectsYersinia infection

Identifiers

PMID39734389
PMCPMC11671063

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.